AbCellera Biologics Inc (NASDAQ: ABCL) is 12.97% higher on its value in year-to-date trading and has touched a low of $2.34 and a high of $6.05 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ABCL stock was last observed hovering at around $3.13 in the last trading session, with the day’s gains setting it 0.18%.
Currently trading at $3.31, the stock is 12.87% and 15.53% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.58 million and changing 5.75% at the moment leaves the stock 4.98% off its SMA200. ABCL registered -44.28% loss for a year compared to 6-month gain of 20.36%. The firm has a 50-day simple moving average (SMA 50) of $2.8544 and a 200-day simple moving average (SMA200) of $3.160175.
The stock witnessed a 14.14% loss in the last 1 month and extending the period to 3 months gives it a 32.40%, and is 10.70% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.49% over the week and 6.25% over the month.
AbCellera Biologics Inc (ABCL) has around 586 employees, a market worth around $1.01B and $32.96M in sales. Profit margin for the company is -533.32%. Distance from 52-week low is 41.76% and -45.33% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.36%).
with sales reaching $7.58M over the same period.The EPS is expected to shrink by -15.13% this year, but quarterly earnings will post -16.95% year-over-year. Quarterly sales are estimated to shrink -17.62% in year-over-year returns.
AbCellera Biologics Inc (ABCL) Top Institutional Holders
200.0 institutions hold shares in AbCellera Biologics Inc (ABCL), with institutional investors hold 55.01% of the company’s shares. The shares outstanding are 295.16M, and float is at 221.93M with Short Float at 7.16%. Institutions hold 39.65% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.4033% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $$64.86 million to account for 7.4852 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.62 million shares representing 3.611% and valued at over $31.45 million, while CAPITAL WORLD INVESTORS holds 1.817 of the shares totaling 5.32 million with a market value of $15.74 million.
AbCellera Biologics Inc (ABCL) Insider Activity
#####
